S-3304
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for S-3304, covering 2011-03-07 to 2018-05-02. Get the full timeline:
Most recent: Clinical Trial Update: Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]